SAN FRANCISCO, Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that details on the 13 first-in-human compassionate use ...
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that details on the 13 first-in-human compassionate use cases ...
The Edwards-CardiAQ mitral valve is anticipated to receive CE Mark in 2018. 2017 is set to be a transformative year for Edwards Lifesciences' transcatheter mitral and tricuspid device pipeline. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results